1. [Rescue chemotherapy in testicular germ cell tumors].
- Author
-
Salazar Soler R, Maroto Rey P, Solà Rocabert C, and López López JJ
- Subjects
- Humans, Male, Neoplasm Recurrence, Local epidemiology, Prognosis, Antineoplastic Agents therapeutic use, Germinoma drug therapy, Testicular Neoplasms drug therapy
- Abstract
Objective: To review the different salvage chemotherapy regimens according to the prognostic factors based on the response to the different therapeutic alternatives., Methods: The conventional rescue chemotherapy regimens, as well as the role of surgery, new drugs and therapeutic modalities, particularly high dose second and third line chemotherapy, were reviewed., Results/conclusions: Germ cell testicular tumor is the paradigm of curable tumors of the adult. Whereas the cure rate for stage I tumors is higher than 98%, patients with advanced stage tumors have a lower cure rate. Approximately 10% of the patients with good-prognosis factors and 30%-50% of those with poor-prognosis factors show tumor progression or recurrence after first line chemotherapy using cisplatin-based combinations. Patients who have recurrence after first line chemotherapy have a 40% probability of achieving second complete remission with second line chemotherapy, but will be sustained in only 20% of the patients, although rare cases of advanced pure seminoma that recurred have shown a cure rate of 55% with second line chemotherapy. New strategies have been developed using new drugs such as taxanes or high doses of well-known chemotherapeutic agents with autologous hematopoietic rescue that have been utilized with success in patients with refractory germ cell testicular tumors. A global analysis of the patients treated with third line chemotherapy shows a sustained complete remission rate of 22%. However, this percentage can only be increased to up to 50% for patients with no adverse factors.
- Published
- 2000